By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


PaxVax, Inc. 

1331 Hillview Drive

Menlo Park  California  94025  U.S.A.
Phone: n/a Fax: n/a



Start Up

Company News
CDC Advisory Committee On Immunization Practices Votes To Recommend Vaxchora, PaxVax, Inc.’s Single-Dose Oral Cholera Vaccine 6/23/2016 10:48:42 AM
FDA Approves PaxVax, Inc. To Manufacture Vaxchora (Oral Cholera Vaccine) At SynCo Bio Partners B.V. 6/20/2016 6:17:50 AM
FDA Approves Vaxchora, PaxVax, Inc.’s Single-Dose Oral Cholera Vaccine 6/13/2016 11:04:54 AM
PaxVax, Inc. Named Best Early-Stage Company At Vaccine Industry Excellence (Vie) Awards 3/30/2016 10:42:37 AM
Bay Area's PaxVax, Inc. Pockets $14 Million 12/9/2015 6:57:48 AM
Bay Area’s PaxVax, Inc. Infused with $105 Million 12/8/2015 9:29:31 AM
PaxVax, Inc. Appoints Nima Farzan Chief Executive Officer 5/11/2015 11:38:17 AM
PaxVax, Inc. Announces Global Expansion Of Commercial Network For Its Typhoid Vaccine Vivotif 4/22/2015 10:27:59 AM
Specialty Vaccine Company PaxVax, Inc. Appoints Nima Farzan As President 1/21/2015 11:24:36 AM
PaxVax, Inc. Announces Primary Endpoints Met In Phase 3 Cholera Vaccine Trial 12/8/2014 2:31:41 PM